EUVIMED · CrossrefZeitschrift
Journal of Crohn's and Colitis Supplements
ISSN 1873-9954 · Oxford University Press (OUP)
Neueste Artikel
Editorial
LONG-TERM OUTCOME OF TREATMENT WITH INFLIXIMAB IN 440 CROHN'S DISEASE PATIENTS: RESULTS FROM A SINGLE CENTER COHORT
O01 TRANSCRIPTION FACTOR XBP1 REGULATES PANETH CELL FUNCTION AND INFLAMMATION IN THE INTESTINE
O02 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA FUNCTIONS AS AN ANTIBACTERIAL FACTOR
O03 CIRCULATING LEVELS OF LEPTIN, ADIPONECTIN AND ALPHA-MSH IN CROHN'S DISEASE PATIENTS DIFFER FROM A MATCHED POPULATION
O04 MULTIDRUG RESISTANCE (MDR) GENE POLYMORPHISMS INFLUENCE OUTCOME OF AZATHIOPRINE AND GLUCOCORTICOIDS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
O05 IDENTIFICATION OF GLI-1 AS AN IBD2 SUSCEPTIBILITY GENE
O06 LONG-TERM RESULTS OF STRICTUREPLASTY IN COMPLICATED CROHN'S DISEASE. A PROSPECTIVE LONGITUDINAL STUDY
O07 LONG-TERM SAFETY OF INFLIXIMAB IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER COHORT STUDY
O08 CONCOMITANT IMMUNOSUPPRESSION DOES NOT IMPACT ON THE OUTCOME OF MAINTENANCE INFLIXIMAB THERAPY IN CROHN'S DISEASE: FINAL RESULTS OF THE IMID TRIAL
O09 SEVERE POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE (CD) IS SIGNIFICANTLY REDUCED WITH COMBINATION THERAPY METRONIDAZOLE + AZATHIOPRINE: A DOUBLE-BLIND CONTROLLED RANDOMIZED TRIAL
O10 SCREENING AND SURVEILLANCE FOR COLORECTAL CARCINOMA IN PATIENTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE: ARE CURRENT SURVEILLANCE GUIDELINES ADEQUATE? INTERIM ANALYSIS OF A RETROSPECTIVE MULTI-CENTER DESCRIPTIVE STUDY
P001 GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IMPROVES MUCOSAL REPAIR DURING ACTIVE DEXTRAN SULFATE SODIUM-INDUCED COLITIS
P002 SERO-REACTIVITY TO MICROBIAL COMPONENTS IN CROHN'S DISEASE IS ASSOCIATED WITH ILEAL INVOLVEMENT, NON-INFLAMMATORY DISEASE BEHAVIOUR AND NOD2/CARD15 GENOTYPE, BUT NOT RESPONSE TO MEDICAL THERAPY OR RISK FOR SURGERY
P003 EARLY SURGERY IN CROHN'S DISEASE
P004 MESALAMINE AND POST-OPERATIVE RECURRENCE IN CROHN'S DISEASE: A RETROSPECTIVE LONG TERM FOLLOW-UP STUDY
P005 HIGH ASSOCIATION BETWEEN WORK PRODUCTIVITY, DAILY ACTIVITIES AND CLINICAL ENDPOINTS IN CROHN'S DISEASE: DATA FROM PRECISE 2
P006 INFLIXIMAB THERAPY IN ULCERATIVE COLITIS: SYSTEMATIC REVIEW AND META-ANALYSIS
P007 THIOPURINE METHYLTRANSFERASE (TPMT) ACTIVITY AND ADVERSE EFFECTS OF AZATHIOPRINE IN INFLAMMATORY BOWEL DISEASE: LONG-TERM FOLLOW-UP STUDY OF 394 PATIENTS
P008 6-THIOGUANINE NUCLEOTIDE (6-TGN) CONCENTRATIONS AND EFFICACY OF AZATHIOPRINE (AZA) AND MERCAPTOPURINE (MP) IN INFLAMMATORY BOWEL DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
P009 THIOPURINE-INDUCED LIVER INJURY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW
P010 5-AMINOSALICYLATES (5-ASAS) AND RENAL FUNCTION IN INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW
P011 CERTOLIZUMAB PEGOL IMPROVES WORK PRODUCTIVITY AND THE ABILITY TO PERFORM DAILY ACTIVITIES IN PATIENTS WITH CROHN'S DISEASE: DATA FROM PRECISE 2
P012 CD-68 POSITIVE CELLS IN BUCCAL MUCOSA AS DIAGNOSTIC MARKER FOR IBD
P013 DISCRIMINATION OF IBD VERSUS IBS: ACCURACY OF FECAL LEUCOCYTE MARKERS IS IMPROVED WHEN COMBINED WITH IBD ANTIBODY PANELS
P014 ESOPHAGEAL STRICTURES IN EOSINOPHILIC ESOPHAGITIS: DILATION IS AN EFFECTIVE AND SAFE ALTERNATIVE AFTER FAILURE OF TOPICAL CORTICOSTEROIDS
P015 THALIDOMIDE IN LUMINAL AND FISTULISING CROHN'S DISEASE RESISTANT TO STANDARD THERAPIES
P016 RECURRENT PROLONGED ANTIGEN ENCOUNTERS ARE NECESSARY FOR 6-MP INDUCED CLONAL DELETION OF ANTIGEN-SPECIFIC MEMORY T-CELLS IN VIVO
P017 SUSPECTED ACUTE ILEITIS. A PROSPECTIVE DIAGNOSTIC PROTOCOL
P018 CERTOLIZUMAB PEGOL IS EFFECTIVE IN PATIENTS REGARDLESS OF CRP LEVEL AND DISEASE DURATION: DATA FROM PRECISE 2
EUVIMED